![Martin Gouldstone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Gouldstone
Algemeen Directeur bij
ONCE HLDG
Vermogen: 5 179 $ op 31-05-2026
Profiel
Martin John Gouldstone is Chief Executive Officer & Director at Oncimmune Holdings Plc since 2023.
He is Chief Executive Officer at Oncimmune Germany.
GmbH.
He is Independent Non-Executive Chairman at ValiRx Plc since 2024.
He is Independent Non-Executive Director at hVIVO Holdings Ltd. since 2022.
Former roles include Independent Non-Executive Director at hVIVO PLC from 2022 to 2025.
Director at Novara Therapeutics Ltd. Director-Corporate Advisory & Head-Life Sciences at BDO UK LLP from 2015 to 2017.
Director-Business Development at Sareum Ltd. from 2006 to 2008.
Director at Orthopaedic Research UK from 2019 to 2024.
Partner at Results Healthcare from 2017 to 2018.
Chief Business Development Officer at Arcturis Data Ltd. from 2021 to 2022.
Global Senior Vice President-Business Development at Owkin, Inc. Chief Business Officer at BenevolentAI SA from 2018 to 2019.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VALIRX PLC 0,27% | 21-11-2025 | 1.969.231 ( 0,27% ) | 5 179 $ | 31-05-2026 |
Actieve functies van Martin Gouldstone
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCE HLDG | Algemeen Directeur | 01-08-2023 |
| HVIVO PLC | Directeur/Bestuurslid | 01-06-2022 |
| VALIRX PLC | Voorzitter | 25-07-2024 |
Oncimmune Germany GmbH
 Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Algemeen Directeur | - |
Eerdere bekende functies van Martin Gouldstone
| Bedrijven | Functie | Einde |
|---|---|---|
| HVIVO PLC | Directeur/Bestuurslid | 05-06-2025 |
Orthopaedic Research UK
 Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services | Directeur/Bestuurslid | 01-03-2024 |
| SENSYNE HEALTH PLC | Corporate Officer/Principal | 01-05-2022 |
| BENEVOLENTAI S.A. | Corporate Officer/Principal | 01-01-2019 |
Results Healthcare
 Results Healthcare Investment ManagersFinance Provides advisory services | Corporate Officer/Principal | 01-06-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
ValiRx Plc
 ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Provides drug discovery services | Retail Trade |
Results Healthcare
Results Healthcare Investment ManagersFinance Provides advisory services | Finance |
Oncimmune Holdings Plc
 Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Orthopaedic Research UK
Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Owkin, Inc.
 Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models | Technology Services |
Sensyne Health Ltd.
 Sensyne Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides statistical analyses and advanced insights to the healthcare industry | Commercial Services |
BDO UK LLP
 BDO UK LLP Miscellaneous Commercial ServicesCommercial Services Provides tax, audit & assurance, advisory and business outsourcing services | Commercial Services |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Health Technology |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
